Medical News

RSS

Spinal cord stimulation could become novel treatment option for heart failure

Spinal cord stimulation improves heart function and could become a novel treatment option for heart failure, according to research presented at the ESC Congress 2012 today, August 25, by Professor Hung-Fat Tse from Hong Kong.

28 Aug 2012

Nicotinamide may combat antibiotic-resistance staph infections

A new study suggests that nicotinamide, more commonly known as vitamin B3, may be able to combat some of the antibiotic-resistance staph infections that are increasingly common around the world, have killed thousands and can pose a significant threat to public health.

28 Aug 2012

Being physically fit also increases the chances of aging healthily

Being physically fit during your 30s, 40s, and 50s not only helps extend lifespan, but it also increases the chances of aging healthily, free from chronic illness, investigators at UT Southwestern Medical Center and The Cooper Institute have found.

28 Aug 2012

Allegro Diagnostics announces results from BronchoGen genomic test trial on lung cancer

Allegro Diagnostics today announced that results from its AEGIS (Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer) clinical trials, to determine the accuracy of the BronchoGen genomic test, have been accepted for an oral presentation during the late-breaking abstract session at CHEST 2012 on Tuesday, October 23, 2012 at 4:30 p.m. The abstract will also be published in a supplement of the October 2012 issue of CHEST.

28 Aug 2012

IASIS Healthcare, Aurora announce collaboration

Aurora Health Care and IASIS Healthcare today announced a wide ranging partnership which includes the formation of a development joint venture, Aurora IASIS Health Partners, to pursue healthcare acquisitions, new construction, management of facilities and development of clinical services with an initial focus on new and existing markets in Wisconsin and northern Illinois.

28 Aug 2012

United Health Products’ HemoStyp gauze receives CE Mark

United Health Products, Inc., which develops and markets products and technologies in the healthcare sector, today announced that its hemostatic gauze, which is registered and branded in the U.S.A. under the trademark HemoStyp, has been granted use of CE mark which is a mandatory conformity mark for products placed on the market in the European Economic Area (EEA), under the application and registration of its manufacturing agent.

28 Aug 2012

Musculoskeletal Transplant Foundation and partners applaud Breast Reconstruction Awareness Day

The Musculoskeletal Transplant Foundation (MTF) today announced its partnership with the American Society of Plastic Surgeons (ASPS) and the Plastic Surgery Foundation (The PSF) in support of the first national Breast Reconstruction Awareness (BRA) Day USA on October 17, 2012.

28 Aug 2012

Haiti at risk of fresh cholera outbreak after tropical storm Isaac hits island nation

"Rain-battered Haiti is at risk of a fresh cholera outbreak" after "tropical storm Isaac ripped through the impoverished Caribbean island Saturday," children's charity Plan International warns, according to AlertNet.

28 Aug 2012

Novartis receives EC approval for Jakavi to treat myelofibrosis

Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.

28 Aug 2012

Nearly 7% of urologic MDCT scans for hematuria result in incidental findings

A new study from Rhode Island Hospital reports that nearly seven percent of urologic multi-detector computed tomography (MDCT) scans for hematuria result in incidental findings that may be clinically important for the patient. The study is published in the American Journal of Roentgenology.

28 Aug 2012

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Alder Biopharmaceuticals Inc. today announced it has received a $3.5 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2 clinical trial of ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6), in Crohn's disease.

28 Aug 2012

Resverlogix enters $25 million Loan Agreement with Citibank

Resverlogix Corp. today announced that it has entered into a $25 million Loan Agreement with Citibank, N.A.. Resverlogix received the $25 million upon closing of the loan.

28 Aug 2012

Views on abortion debate: Akin's defiance hurts Romney; Sen. Snowe on mending the GOP's image

Rep. Todd Akin doesn't look like he's going away. And that's a problem for Mitt Romney, the presumed Republican nominee. Akin's open defiance makes Romney look like a figurehead. After Romney joined other Republican Party leaders urging Akin to step down as the Republican Senate candidate in Missouri, Akin told the nominee to mind his own business. "Don't you think he may have built this thing up and made a bigger deal about it than he needed to?" Akin said on Sean Hannity's radio show. "Why couldn't he run his race and I'll run mine?"

28 Aug 2012

Reducing TV viewing may effectively prevent excess weight gain among adolescents

Reducing television viewing may be an effective strategy to prevent excess weight gain among adolescents, according to a new study released in the September/October 2012 issue of the Journal of Nutrition Education and Behavior.

28 Aug 2012

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.

28 Aug 2012

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.

28 Aug 2012

Viewpoints: Health law will leave some poor families 'in lurch'; Mich. Gov.'s effort to get health exchange

Confusing language in the health care reform law has raised the possibility that millions of Americans living on modest incomes may be unable to afford their employers' family policies and yet fail to qualify for government subsidies to buy their own insurance. This is a bizarre development that undercuts the basic goal of health care reform - to expand the number of insured people and make their coverage affordable.

28 Aug 2012

Medical News

Spinal cord stimulation could become novel treatment option for heart failure

Nicotinamide may combat antibiotic-resistance staph infections

Being physically fit also increases the chances of aging healthily

Allegro Diagnostics announces results from BronchoGen genomic test trial on lung cancer

IASIS Healthcare, Aurora announce collaboration

United Health Products’ HemoStyp gauze receives CE Mark

Musculoskeletal Transplant Foundation and partners applaud Breast Reconstruction Awareness Day

Haiti at risk of fresh cholera outbreak after tropical storm Isaac hits island nation

Novartis receives EC approval for Jakavi to treat myelofibrosis

Nearly 7% of urologic MDCT scans for hematuria result in incidental findings

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Resverlogix enters $25 million Loan Agreement with Citibank

Views on abortion debate: Akin's defiance hurts Romney; Sen. Snowe on mending the GOP's image

Reducing TV viewing may effectively prevent excess weight gain among adolescents

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

Viewpoints: Health law will leave some poor families 'in lurch'; Mich. Gov.'s effort to get health exchange

Matrix Medical Network announces acquisition of Ascender

Leg compressions after stroke appear to trigger natural protective mechanisms that reduce damage

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

The importance of ketones from a clinical and medical perspective

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Latest News